Compare AFLAC Incorporated (AFL) vs Expensify Inc (EXFY) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AFLAC Incorporated vs Expensify Inc — how do they compare? AFLAC Incorporated trades at $121.22 (market cap $61.84B), while Expensify Inc trades at $1.88 (market cap $179.86M). The key difference: AFLAC Incorporated is far larger — about 343.8× Expensify Inc's market cap, and AFLAC Incorporated pays a 2.01% dividend while Expensify Inc pays none. Which is the better fit depends on your goals.
| AFL | EXFY | |
|---|---|---|
Market Cap | $61.84B | $179.86M |
Sector | Financials | Technology |
52-Week High | $121.49 | $2.51 |
52-Week Low | $98.09 | $0.75 |
Enterprise Value | $70.50B | $118.89M |
Dividend Yield | 2.01% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aflac (AFL) trades at $121.49, up 0.5% with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with a 25.32% net income margin and 16.47% ROE, though recent Q1 2026 earnings missed expectations. Analyst consensus is mixed with 28% buy ratings and a $113.57 price target below current levels. Recent developments include strong dividend performance and upcoming Q2 2026 results announcement on August 6, 2026.
The outlook remains cautiously optimistic with solid profitability and dividend stability, but faces headwinds from recent earnings misses and premium valuation pressure. Key opportunities include continued growth in Japan and U.S. markets, while risks involve medical cost inflation and uneven revenue trends. The stock's current premium to analyst targets suggests limited near-term upside potential.
Expensify (EXFY) trades at $1.71, up 0.59% with a bullish technical signal from moving averages. The company maintains strong revenue around $142M but continues to report net losses, with a negative net income margin of -14.68%. Recent developments include AI product expansions and a $25M stock buyback program. Analyst sentiment is mixed with a 44% buy rating, while technical indicators show RSI levels suggesting potential overbought conditions near-term.
The outlook remains challenging with persistent profitability issues despite stable revenue. Investment opportunity exists in the company's AI initiatives and market positioning, but risks include ongoing losses, competitive pressure, and execution challenges. The stock's high P/E ratio of 258.82 reflects growth expectations that must materialize to justify current valuation levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AFLAC Incorporated
Aflac Inc offers supplemental health insurance and life insurance in the two largest insurance markets in the world, the U.S. and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accidents, disability, and long-term-care insurance. It markets its products through independent distributors, selling most of its policies directly to consumers at their places of work.
Read more on AFL →About Expensify Inc
Expensify Inc is a cloud-based expense management software platform that helps the smallest to the largest businesses simplify the way they manage money. More than 10 million people use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay, and travel booking in one app.
Read more on EXFY →
